4.7 Article

Sequestration of LINE-1 in cytosolic aggregates by MOV10 restricts retrotransposition

Journal

EMBO REPORTS
Volume 23, Issue 9, Pages -

Publisher

WILEY
DOI: 10.15252/embr.202154458

Keywords

LINE-1; miRNA; retrotransposition; MOV10; cytosolic aggregates

Funding

  1. Swiss National Science Foundation [31003A_173120, 310030_196861]
  2. Novartis Foundation for Medical-Biological Research [19A018]
  3. NCCR RNA and Disease (Swiss National Science Foundation) [182880]
  4. Eidgenossische Technische Hochschule Zurich
  5. Swiss National Science Foundation (SNF) [31003A_173120, 310030_196861] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

This study reveals that alternative mechanisms exist to regulate the activity of L1 retroelements during early stages of mouse embryonic development. L1 ribonucleoprotein complexes and the RNA helicase MOV10 form aggregates in the cytoplasm, preventing L1 retrotransposition. Understanding these mechanisms could lead to potential therapeutic strategies for diseases associated with upregulated L1 activity.
LINE-1 (L1) retroelements have retained their ability to mobilize. Mechanisms regulating L1 mobility include DNA methylation in somatic cells and the piRNA pathway in the germline. During preimplantation stages of mouse embryonic development, however, both pathways are inactivated leading to a window necessitating alternate means of L1 regulation. We previously reported an increase in L1 levels in Dicer_KO mouse embryonic stem cells (mESCs), which was accompanied by only a marginal increase in retrotransposition, suggesting additional mechanisms suppressing L1 mobility. Here, we demonstrate that L1 ribonucleoprotein complexes (L1 RNP) accumulate as aggregates in the cytoplasm of Dicer_KO mESCs along with the RNA helicase MOV10. The combined overexpression of L1 ORF1p and MOV10 is sufficient to create L1 RNP aggregates. In Dicer_KO mESCs, MOV10 is upregulated due to the loss of its direct regulation by miRNAs. The newly discovered posttranscriptional regulation of Mov10, and its role in preventing L1 retrotransposition by driving cytosolic aggregation, provides routes to explore for therapy in disease conditions where L1s are upregulated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available